Pepzilla

Loading catalog

Pulling latest protocols

Encyclopedia / Body composition

Ipamorelin 10 mg.

Unlock potent growth hormone release with targeted receptor action.

Body compositionGH axisSubcutaneous or intramuscular injection

Evidence

What the research shows

Ipamorelin is a potent growth hormone secretagogue with a unique mechanism of action that selectively targets the ghrelin receptor. In preclinical studies, it has demonstrated significant potential for stimulating growth hormone release while minimizing side effects associated with other secretagogues. Research indicates that its targeted receptor profile can enhance the understanding of metabolic and endocrine responses, making it a valuable tool for scientists exploring these pathways.

Protocol

Cycle and dosing notes

Administer 200-300 mcg of Ipamorelin subcutaneously once daily, ideally at bedtime to mimic natural growth hormone release patterns. For optimal results, consider a cycle of 12 weeks followed by a 4-week break to allow your body to reset. Always ensure proper laboratory conditions for administration and monitoring.

Safety

What to watch for

Not medical advice. Ipamorelin is intended solely for laboratory research use and is not approved for human consumption. Side effects may include injection site reactions. Ensure compliance with all relevant regulations and guidelines for laboratory research.

Best for

Who benefits most

Ideal for researchers and biohackers focused on the intricate dynamics of growth hormone and metabolic regulation. If you are at the forefront of peptide research, Ipamorelin offers a sophisticated tool for your studies.

Not for

Who should avoid it

Not suitable for individuals seeking therapeutic benefits or those not engaged in controlled laboratory research.

Build your stack

Ipamorelin 10 mg works best inside a protocol.

Pepzilla matches it with the right companions, dosing, and lifestyle rails for your goals — calibrated in 60 seconds.